- Nā lāʻau lapaʻau
- Nā Hōʻike Manaʻo
- ʻO ka Neuroblastoma
- Puʻupuʻu paʻa
- Nā Hōʻike Manaʻo
- TILS
- NK Cell Therapy
- ʻO ka Myasthenia Gravis (MG)
- ʻO ka maʻi leukemia lymphoblastic koʻikoʻi (B-ALL)
- ʻO ka Lupus Erythematosus Pūnaehana (SLE)
- ʻO ka maʻi leukemia lymphoblastic koʻikoʻi (T-ALL)
- ʻO ka Lymphoma Non-Hodgkin (NHL)
- ʻO ka Myeloma Nui (MM)
- ʻO ka Lymphom cell B nui e hoʻolaha ʻia
- ʻO ka maʻi leukemia lymphocytic B
- Myeloma
ʻO Mr. A ----Lymphoma cell B nui i hoʻolaha ʻia (DLBCL)
Ua hoʻomaka ʻo Mr. A, no India mai, he kanaka ikaika 66 makahiki, i kāna huakaʻi lapaʻau i ʻApelila 2018. Ma hope o ka biopsy o kahi puʻupuʻu ma kona lima hema, a me kahi scan PET-CT piha o ke kino holoʻokoʻa, ua hāʻawi ʻia ka maʻi o Diffuse Large B-Cell Lymphoma (DLBCL). Ua hōʻailona kēia i ka hoʻomaka ʻana o kahi papa hana lapaʻau koʻikoʻi e pili ana i ka hakakā ʻana i ka maʻi.
Ma hope o ka hana ʻana i ʻeono mau pōʻaiapuni o ka regimen chemotherapy R-EPOCH, ua hoʻololi ʻo Mr. A i ʻekolu mau pōʻaiapuni o ka regimen R-GDP, a ukali ʻia e ʻelua mau pōʻaiapuni hou o ia mea. Ua hoʻomaka kēia regimen chemotherapy ikaika mai ʻApelila 2018 a ʻOkakopa 2019, kahi wā i hōʻailona ʻia e ke ahonui a me ke kūpaʻa i ke alo o ka pilikia.
ʻOiai ke ʻano paʻakikī o ka mālama ʻana, ua puka mai kahi pilikia i ka wā o ka loiloi hou ʻana o ka PET-CT i ʻOkakopa 2019, e hōʻike ana i nā hewa metabolic hou ma ka ʻāpana calcaneus ʻākau a me ka femur distal ʻākau. Me ka wiwo ʻole, ua ʻimi ʻo Mr. A, me ka ʻike o ka ʻokoʻa o BIOOCUS Medical Group ma ke ʻano he kikowaena CAR-T mua loa ma ka honua holoʻokoʻa, i kona ʻike loea.
Ua hōʻailona ʻo Nowemapa 2019 i kahi huli koʻikoʻi i ka hoʻomaka ʻana o Mr. A i kahi pae hou o ka mālama ʻana ma lalo o ka mālama ʻana a kā mākou hui lapaʻau. Ua hōʻike nā hoʻokolohua piha i ka CD19 dim-positive a me ka CD22 maikaʻi ikaika loa, e hōʻike ana i ka hana tumor koena kiʻekiʻe. Ma muli o kēia mau ʻike, ua hoʻoholo ʻia e hoʻomau me ka lāʻau lapaʻau CD19+CD22 CAR-T cell, kahi ala holomua i mākaukau e hoʻoponopono i ka maʻi ʻino mau loa.
Ma hope o ke kanu ʻana, ua loaʻa iā Mr. A kahi Cytokine Release Syndrome (CRS) kekelē 2 i hiki ke hoʻokele ʻia, a ua hoʻōla koke ʻo ia ma hope. I Ianuali 2020, ua hoʻokuʻu ʻia ʻo ia, me ka hoʻoikaika ʻia e nā hopena hoʻohiki mai ka PET-CT scan hou loa e hōʻike ana i ka emi ʻana o ka puʻupuʻu a me ka emi nui ʻana o ka hana metabolic.
ʻO ka huakaʻi a Mr. A he kukui o ka manaʻolana, e hōʻike ana i ka hiki ke hoʻololi i nā hana lapaʻau holomua i ke kahua o ka oncology. I kona hoʻomaka ʻana i kahi papa hana hahai lōʻihi ma waho o ka haukapila, ke kau nei ka manaʻo ma ka hoʻomau ʻana i ka ikaika hou a me ka pale ʻana i ka hoʻi hou ʻana o ka maʻi.
wehewehe2
Submit An Free Inquiry
Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

